Sigrid Eckard | Authors


Treatment Sequencing Considerations for BRAF-Mutant Melanoma

May 26, 2016

With expanding availability of effective single-agent and combination immunotherapies and combination BRAF/MEK inhibitor regimens, all of which have been shown to improve survival and reduce risk of progression, the optimal sequencing of therapies has become increasingly complex.